Predictions
Pfizer Inc.
Start price
Target price
Perf. (%)
€46.84
04.04.22
04.04.22
€55.00
04.04.23
04.04.23
2.48%
16.04.22
16.04.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
Pfizer Inc.
Start price
Target price
Perf. (%)
€47.88
25.03.22
25.03.22
€64.00
25.03.23
25.03.23
-21.14%
27.03.23
27.03.23
Could be worthwhile Investment >10% per year
Pfizer Inc.
Start price
Target price
Perf. (%)
€48.26
23.03.22
23.03.22
€55.00
23.03.23
23.03.23
-3.61%
02.04.22
02.04.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
Pfizer Inc.
Start price
Target price
Perf. (%)
€50.01
03.01.22
03.01.22
€78.00
03.01.23
03.01.23
-2.98%
04.01.23
04.01.23
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Undervalued
Johnson & Johnson
Start price
Target price
Perf. (%)
€149.96
28.12.21
28.12.21
-
28.12.22
28.12.22
10.44%
29.12.22
29.12.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Good culture
Top 10 in its market
Pfizer Inc.
Start price
Target price
Perf. (%)
€52.51
22.12.21
22.12.21
€55.00
22.12.22
22.12.22
-7.45%
23.12.22
23.12.22
Could be worthwhile Investment >10% per year
Johnson & Johnson
Start price
Target price
Perf. (%)
€147.94
22.12.21
22.12.21
-
22.12.25
22.12.25
1.31%
28.12.21
28.12.21
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Fair valuation
Innovative
Pfizer Inc.
Start price
Target price
Perf. (%)
€48.36
06.12.21
06.12.21
€60.00
06.12.22
06.12.22
-0.12%
06.12.22
06.12.22
Could be worthwhile Investment >10% per year
Johnson & Johnson
Start price
Target price
Perf. (%)
€140.70
27.11.21
27.11.21
€160.00
27.11.22
27.11.22
21.35%
28.11.22
28.11.22
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Pfizer Inc.
Start price
Target price
Perf. (%)
€41.11
09.11.21
09.11.21
€60.00
09.11.22
09.11.22
14.73%
19.01.22
19.01.22
Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€70.70
05.11.21
05.11.21
€60.00
31.12.23
31.12.23
28.01%
24.08.22
24.08.22
Could be worthwhile Investment >10% per year
Pfizer Inc.
Start price
Target price
Perf. (%)
€42.04
05.11.21
05.11.21
€70.00
31.12.24
31.12.24
11.00%
02.09.22
02.09.22
Could be worthwhile Investment >10% per year
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€70.76
26.10.21
26.10.21
€65.00
26.10.22
26.10.22
38.64%
27.10.22
27.10.22
Could be worthwhile Investment >10% per year
Pfizer Inc.
Start price
Target price
Perf. (%)
€39.50
28.08.21
28.08.21
-
28.08.22
28.08.22
0.10%
04.09.21
04.09.21
Risky Investment
Pfizer Inc.
Start price
Target price
Perf. (%)
€33.31
09.07.21
09.07.21
-
09.07.22
09.07.22
0.27%
09.07.21
09.07.21
Top 10 in its market
Small cyclical dependencies
Pfizer Inc.
Start price
Target price
Perf. (%)
€33.21
08.07.21
08.07.21
€55.00
08.07.22
08.07.22
29.12%
18.02.22
18.02.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
Johnson & Johnson
Start price
Target price
Perf. (%)
€142.86
08.07.21
08.07.21
€177.00
08.07.22
08.07.22
22.71%
08.07.22
08.07.22
Johnson & Johnson
Start price
Target price
Perf. (%)
€136.62
24.03.21
24.03.21
€145.00
24.03.22
24.03.22
-1.26%
09.04.21
09.04.21
Known brand
Future proof or reliable business model
Medium risks for its business
Pfizer Inc.
Start price
Target price
Perf. (%)
€29.35
15.03.21
15.03.21
€50.00
15.03.22
15.03.22
43.43%
09.11.21
09.11.21
Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Johnson & Johnson
Start price
Target price
Perf. (%)
€138.90
05.02.21
05.02.21
-
31.12.21
31.12.21
0.09%
29.03.21
29.03.21
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Fair valuation
Innovative
Johnson & Johnson
Start price
Target price
Perf. (%)
€134.68
20.01.21
20.01.21
€144.00
0.89%
02.02.21
02.02.21
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Fair valuation
Innovative
Pfizer Inc.
Start price
Target price
Perf. (%)
€31.01
18.12.20
18.12.20
€34.00
18.12.21
18.12.21
-5.35%
15.03.21
15.03.21
Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques